With the use of various TGF-β inhibitors before TGF-β1 treatment and virus infection, we found that LY364947 and SB431542, inhibitors of TGF-β1/Smad signaling, could inhibit the enhancement of RuV infectivity in the TGF-β1-treated A549 cells. Here, TGFB1 is linked to viral infectious disease.